Clinical Trial Update: Carboplatin and Bevacizumab for Progressive Breast Cancer Brain Metastases [Phase 2]

View source ↗

Summary

Phase 2 trial evaluating carboplatin combined with bevacizumab for progressive brain metastases from breast cancer has completed with results posted.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Brain Metastases
• Breast Cancer

Drugs mentioned

• Carboplatin + Bevacizumab

Snippet

Sponsor: Dana-Farber Cancer Institute | Conditions: Metastatic Breast Cancer, Breast Cancer | Phase 2 | Status: COMPLETED | Results posted: 2017-05-22